Expert Opinion On Therapeutic Targets

Expert Opinion On Therapeutic Targets英文簡介

The journal evaluates molecules, signalling pathways, receptors and other therapeutic targets and their potential as candidates for drug development. Articles in this journal focus on the molecular level and early preclinical studies. Articles should not include clinical information including specific drugs and clinical trials.

The Editors welcome:

Reviews covering novel disease targets at the molecular level and information on early preclinical studies and their implications for future drug development.

Articles should not include clinical information including specific drugs and clinical trials.

Original research papers reporting results of target selection and validation studies and basic mechanism of action studies for investigative and marketed drugs.

The audience consists of scientists, managers and decision makers in the pharmaceutical industry, academic researchers working in the field of molecular medicine and others closely involved in R&D.

Expert Opinion On Therapeutic Targets中文簡介

《Expert Opinion On Therapeutic Targets》是一本由TAYLOR & FRANCIS LTD出版商出版的專業醫學期刊，該刊創刊于2001年，刊期Monthly，該刊已被國際權威數據庫SCIE收錄。在中科院最新升級版分區表中，該刊分區信息為大類學科：醫學 2區，小類學科：藥學 2區；在JCR（Journal Citation Reports）分區等級為Q1。該刊發文范圍涵蓋藥學等領域，旨在及時、準確、全面地報道國內外藥學工作者在該領域取得的最新研究成果、工作進展及學術動態、技術革新等，促進學術交流，鼓勵學術創新。2021年影響因子為6.797，平均審稿速度偏慢,4-8周。

中科院分區最新升級版（當前數據版本：2021年12月最新升級版）

大類學科	分區	小類學科	分區	Top期刊	綜述期刊
醫學	2區	PHARMACOLOGY & PHARMACY 藥學	2區	否	是

JCR分區（當前數據版本：2021-2022年最新版）

JCR分區等級	JCR所屬學科	分區	影響因子
Q1	PHARMACOLOGY & PHARMACY	Q1	6.797

期刊指數

影響因子	h-index	Gold OA文章占比	研究類文章占比	OA開放訪問	平均審稿速度
6.797	78	4.55%	22.86%	未開放	偏慢,4-8周

IF值(影響因子)趨勢圖